Baker Bros. Buy Some Shares of Mirati Therapeutics

Baker Bros., Mirati Therapeutics: In a new form 4 from today, Julian and Felix Baker's Baker Bros. Advisors reported buying 400,000 shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX). Following the transaction, Baker Bros own an aggregate amount of some 2.4 million shares. The shares have been purchased in terms of an underwritten public offering of Mirati Therapeutics, the per-share price amounting to $17.5 apiece.

Mirati Therapeutics, Inc

Disclosure: none

Recommended Reading:

The 10 Main Hedge Fund Moves of the Past Seven Days

Weiss Asset Management Lowers Its Position in LSE-listed Tamar

Outerwall Listens to Jana — Should You?

Sign Up

Get the InvestingChannel
Free e-Letter Today

Learn More

Independent market opinion, analysis and ideas - delivered every business day

Premium market opinions, analysis, and ideas - delivered every business day

Editor's Picks